ABSTRACT
El síndrome de Smith-Lemli-Opitz (SSLO) es un desorden metabólico autosómico recesivo debido a la síntesis anormal de colesterol y fue descrito por primera vez por Smith, Lemli y Opitz en 1964. Muchos casos de SSLO han sido descritos desde entonces, siendo reconocido como un síndrome malformativo relativamente común. Los individuos afectados tienen dismorfismo, microcefalia, múltiples malformaciones congénitas, retraso mental, agresividad e hiperactividad. La severidad de los defectos físicos se correlaciona con la severidad de la deficiencia de colesterol, la cual es causada por la baja actividad de la 7-dehidrocolesterol reductasa, enzima responsable de la conversión de 7-dehidrocolesterol a colesterol. La ocurrencia de hipotiroidismo en asociación con SSLO es muy inusual. Este constituye el primer caso venezolano en el que se asocian ambas patologías.
The Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive metabolic disorder due to an abnormal cholesterol synthesis. It was first described by Smith, Lemli and Opitz in 1964. Many cases of SLOS have been described since then, leading to the recognition as a relatively common malformation syndrome. Affected individuals have dysmorphism, microcephaly, multiple congenital malformations, mental retardation, aggressiveness and hyperactivity. The severity of physical defects correlates with the severity of the cholesterol deficiency, which is caused by an abnormally low activity of 7-dehydrocholesterol reductase, the enzyme responsible for conversion of 7-dehydrocholesterol to cholesterol. The occurrence of hypothyroidism in association with SLOS is very unusual. We describe the first Venezuelan case in which both anomalies are associated.
Subject(s)
Child, Preschool , Humans , Male , Hypothyroidism/complications , Smith-Lemli-Opitz Syndrome , Hypothyroidism/diagnosis , Phenotype , Smith-Lemli-Opitz Syndrome/diagnosis , VenezuelaABSTRACT
El síndrome de Smith-Lemli-Opitz es una rara enfermedad hereditaria de transmisión autosómica recesiva. Se caracteriza por presenta hipocolesterolemia como consecuenciade una mutación del gen 7-deshidrocolesterol reductasa (7DHCR), lo que produce retrasomental, retardo en el crecimiento, microcefalia, micrognatismo y otras anomalías neurológicas sistémicas y físicas. Se presenta el caso de un paciente de tres años y nueve mesesafectado por este síndrome, quien acudió a la clínica de odontología pediátrica de la Facultad de Odontología de la Universidad Autónoma de Baja California, Tijuana, donde se inició historia médica y dental. Debido a su corta edad, la presencia de múltiples lesiones cariosas, conducta incontrolable, retraso mental y compromiso sistémico, se decidió realizar larehabilitación oral del paciente bajo anestesia general, la cual se describe detalladamente...
Smith-Lemli-Opitz syndrome is a rare autosomal recessive hereditary disease. It is caused by a mutation in the 7-dehydrocholesterol reductase (DHCR7) gene producing hypocholesterolemia,and consequence mental retardation, delayed growth, microcephaly, micrognathia and other systemic neurological and physical features. A case of a three-year-ninemonth-old patient affected by this syndrome who attended the Pediatric Dental Clinic of the Universidad Autónoma de Baja California Dental School at Tijuana is presented. Afterdoing medical and dental records and because of his young age, multiple dental cavities, uncontrollable behavior, mental retardation and medical status, oral rehabilitation under general anesthesia was performed. The anesthesia procedure is detailed...
Subject(s)
Child , Pediatric Dentistry , Smith-Lemli-Opitz Syndrome/diagnosis , Smith-Lemli-Opitz Syndrome/rehabilitation , Smith-Lemli-Opitz Syndrome/therapy , Oral MedicineABSTRACT
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive malformation syndrome caused by a defect in cholesterol biosynthesis. The incidence is very low in Asians and only one case has been reported in Korea thus far. Recently, we found an infant with neonatal cholestasis. He had microcephaly, ambiguous genitalia, cleft palate, syndactyly of toes, patent ductus arteriosus and hypertrophic pyloric stenosis. The serum cholesterol was decreased and serum 7-dehydrocholesterol was markedly elevated. Genetic analysis of the DHCR7 gene identified a novel missense mutation (Pro227Ser) as well as a known mutation (Gly303Arg) previously identified in a Japanese patient with SLOS. Although rare in Korea, SLOS should be considered in the differential diagnosis of neonatal cholestasis, especially in patients with multiple congenital anomalies and low serum cholesterol levels.
Subject(s)
Humans , Infant, Newborn , Male , Amino Acid Substitution , Base Sequence , Cholestasis/diagnosis , Ductus Arteriosus, Patent/diagnosis , Electroencephalography , Liver/pathology , Mutation, Missense , Oxidoreductases Acting on CH-CH Group Donors/genetics , Phenotype , Smith-Lemli-Opitz Syndrome/diagnosisABSTRACT
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder due to an inborn error of cholesterol metabolism, characterized by congenital malformations, dysmorphism of multiple organs, mental retardation and delayed neuropsychomotor development resulting from cholesterol biosynthesis deficiency. A defect in 3ß-hydroxysteroid-delta7-reductase (delta7-sterol-reductase), responsible for the conversion of 7-dehydrocholesterol (7-DHC) to cholesterol, causes an increase in 7-DHC and frequently reduces plasma cholesterol levels. The clinical diagnosis of SLOS cannot always be conclusive because of the remarkable variability of clinical expression of the disorder. Thus, confirmation by the measurement of plasma 7-DHC levels is needed. In the present study, we used a simple, fast, and selective method based on ultraviolet spectrophotometry to measure 7-DHC in order to diagnose SLOS. 7-DHC was extracted serially from 200 æl plasma with ethanol and n-hexane and the absorbance at 234 and 282 nm was determined. The method was applied to negative control plasma samples from 23 normal individuals and from 6 cases of suspected SLOS. The method was adequate and reliable and 2 SLOS cases were diagnosed
Subject(s)
Child, Preschool , Humans , Male , Infant , Child , Cholesterol , Dehydrocholesterols , Smith-Lemli-Opitz Syndrome/diagnosis , Biomarkers , Smith-Lemli-Opitz Syndrome/blood , Spectrophotometry, UltravioletABSTRACT
Os autores relatam o caso de uma crianca com Sindrome de Smith-Lemli-Opitz, que era acompanhada por varias especialidades de forma especializada. A relevancia desse caso e destacar o atendimento do paciente como um todo...
Subject(s)
Humans , Male , Infant , Abnormalities, Multiple/diagnosis , Chromosome Aberrations , Smith-Lemli-Opitz Syndrome/diagnosis , Genetic CounselingABSTRACT
El síndrome de Smith-Lemli-Opitz es una entidad de etiología autosómica recesiva, que cursa con malformaciones congénitas, retraso del crecimiento y desarrollo pre y posnatal y es causa de muerte a temprana edad. No se conoce tratamiento, por lo que solamente se cuenta con el asesoramiento genético para evitar la aparición de nuevos casos.Se presenta el caso de dos hermanos, hijos de padres consanguíneos. Ambos fueron detectados desde el nacimiento y aun cuando se diagnosticaron al mes de vida, el asesoramiento genético proporcionando a los padres no fue efectivo, ya que después del primer hijo afectado tuvieron dos embarazos más, resultando afectado el producto del segundo de éstos. Se ha encontrado una deficiencia en la síntesis de colesterol, por lo que es posible hacer el diagnóstico prenatal en las mujeres que tienen antecedentes de gestas previas con esta enfermedad